Your browser doesn't support javascript.
loading
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy.
Gupta, Yash; Maciorowski, Dawid; Zak, Samantha E; Kulkarni, Chandrashekhar V; Herbert, Andrew S; Durvasula, Ravi; Fareed, Jawed; Dye, John M; Kempaiah, Prakasha.
Afiliação
  • Gupta Y; Infectious Diseases, Mayo Clinic, Jacksonville, FL, USA.
  • Maciorowski D; Loyola University Chicago, Chicago, IL, USA.
  • Zak SE; United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA; The Geneva Foundation, 917 Pacific Avenue, Tacoma, WA, USA.
  • Kulkarni CV; School of Natural Sciences, University of Central Lancashire, Preston, UK.
  • Herbert AS; United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.
  • Durvasula R; Infectious Diseases, Mayo Clinic, Jacksonville, FL, USA.
  • Fareed J; Department of Molecular Pharmacology & Neuroscience, Loyola University Chicago, Chicago, IL, USA.
  • Dye JM; United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA; The Geneva Foundation, 917 Pacific Avenue, Tacoma, WA, USA.
  • Kempaiah P; Infectious Diseases, Mayo Clinic, Jacksonville, FL, USA. Electronic address: Kempaiah.Prakasha@mayo.edu.
Int J Biol Macromol ; 183: 203-212, 2021 Jul 31.
Article em En | MEDLINE | ID: mdl-33915212
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Heparina / Reposicionamento de Medicamentos / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Heparina / Reposicionamento de Medicamentos / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 Idioma: En Ano de publicação: 2021 Tipo de documento: Article